Kennedy PBM Bill Has Embedded Price Controls, PhRMA Tells Finance Cmte.
Executive Summary
Benchmark pricing provisions in Sen. Kennedy's (D-Mass.) pharmacy benefit management-based Medicare drug benefit proposal would represent de facto government price controls, Pharmaceutical Research & Manufacturers of America President Alan Holmer said in testimony to the Senate Finance Committee.